Using zinc finger nuclease technology to generate reporter-labelled human pluripotent stem cells as a tool to optimize photoreceptor transplantation

使用锌指核酸酶技术生成报告基因标记的人类多能干细胞作为优化光感受器移植的工具

基本信息

  • 批准号:
    BB/I02333X/1
  • 负责人:
  • 金额:
    $ 15.24万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2011
  • 资助国家:
    英国
  • 起止时间:
    2011 至 无数据
  • 项目状态:
    已结题

项目摘要

Pluripotent stem cells are unspecialized cells that can be grown in the laboratory and programmed to become specialized cells of a desired type, such as blood cells, muscle cells etc. Human pluripotent stem cells can be derived in different ways, from very early embryos when they become available as surplus products during in vitro fertilization, or more generally by re-programming easily accessible cells from individuals, such as from a sample of skin cells. This possibility has led to great interest in using stem cells for therapeutic applications to treat disorders caused by loss of cells of a particular type. For example, blindness due to loss of retinal cells could in principle be treated by taking a sample of skin cells from the patient, re-programme the skin cells to make unspecialized pluripotent stem cells and then programme the resulting stem cells to give retinal cell progenitors that can be grafted into the patient's eye to give rise to retinal cells. One of the difficult problems in differentiating human pluripotent stem cells is to track the cells as they change into specialized cells and then to purify the desired specialized cells. This can be done relatively easily for mouse pluripotent stem cells by inserting genes that make reporter molecules tagged with a fluorescent that makes the cells glow under suitable conditions, but the method is very inefficient in human pluripotent stem cells. A new cutting edge technology now offers a potential solution. Zinc finger nucleases are artificially created scissors that can be designed to specifically cut both strands of DNA molecules at just one specific location. These nucleases create a gap in the DNA structure which activates the cell's response for DNA repair. Upon presence of a short DNA stretch which shows similarity to the region containing the excision but also harbouring the reporter gene, it is possible to introduce the reporter gene into the gene of interest in human pluripotent stem cells. This technology is very recent and has only been applied twice in human pluripotent stem cells; however the efficiency has been much higher than other reported methods and as such the potential applications are immense. In this proposal we seek to implement this technology to create labelled human pluripotent stem cells lines that will be used as tools to optimise cell transplantation into the degenerate retina. The retina has a very complex structure consisting of several layers of neurons that are interconnected with each other. The two main cell types that are directly sensitive to light are the rod and cone photoreceptors cells. Our group has shown that it is possible to produce human cells that have the characteristics of cones and rods from human pluripotent stem cells. Despite this progress, we are not able to select these cells amongst other cell types that arise during differentiation process. Normally cell selection is achieved using a technique called fluorescence activated cell sorting (FACS). The different cells of the body have specific proteins on their surface to which antibodies tagged with coloured or fluorescent molecules can bind, allowing us to identify and sort them using FACS, however, there are few such markers that can be used for isolating cones and rods. We intend to introduce a reporter into an important retinal gene that marks their differentiation to cone and rods. The presence of the fluorescent reporter will allow us to use the cell selection strategy mentioned above to purify these cells. We can then ask the question of whether these cells exhibit the properties associated with rods and cones using a variety of in vitro stem cell assays and electrophysiological analysis. If successful, this approach will allow us to prospectively isolate rod and cone cells, define their molecular phenotype and test their ability to restore vision in animal models of retinal disease.
多能干细胞是可以在实验室中生长并被编程为所需类型的特化细胞的非特化细胞,例如血细胞、肌肉细胞等。人类多能干细胞可以以不同的方式衍生,当它们在体外受精期间作为剩余产物时来自非常早期的胚胎,或者更一般地通过重新编程来自个体的容易获得的细胞,例如来自皮肤细胞样品。这种可能性已经引起了对使用干细胞用于治疗应用以治疗由特定类型的细胞损失引起的病症的极大兴趣。例如,由于视网膜细胞丢失而导致的失明原则上可以通过从患者身上提取皮肤细胞样本来治疗,重新编程皮肤细胞以产生非特异性多能干细胞,然后编程所得干细胞以产生视网膜细胞祖细胞,这些视网膜细胞祖细胞可以移植到患者的眼睛中以产生视网膜细胞。分化人类多能干细胞的困难问题之一是在细胞转变为特化细胞时对其进行跟踪,然后纯化所需的特化细胞。对于小鼠多能干细胞,这可以相对容易地通过插入基因来完成,这些基因使报告分子标记有荧光,使细胞在合适的条件下发光,但该方法在人类多能干细胞中效率非常低。一项新的尖端技术现在提供了一个潜在的解决方案。锌指核酸酶是人工制造的剪刀,可以被设计成在一个特定位置特异性地切割DNA分子的两条链。这些核酸酶在DNA结构中产生缺口,激活细胞对DNA修复的反应。当存在显示与含有切除的区域相似但也包含报道基因的短DNA片段时,可以将报道基因引入人多能干细胞中的目的基因中。这项技术是非常新的,只在人类多能干细胞中应用过两次;然而,效率比其他报道的方法高得多,因此潜在的应用是巨大的。在这项提案中,我们寻求实施这项技术来创建标记的人类多能干细胞系,这些干细胞系将用作优化细胞移植到退化视网膜中的工具。视网膜有一个非常复杂的结构,由几层相互连接的神经元组成。直接对光敏感的两种主要细胞类型是视杆细胞和视锥细胞。我们的研究小组已经证明,从人类多能干细胞中产生具有视锥细胞和视杆细胞特征的人类细胞是可能的。尽管取得了这一进展,但我们无法在分化过程中出现的其他细胞类型中选择这些细胞。通常,细胞选择使用称为荧光激活细胞分选(FACS)的技术来实现。身体的不同细胞在其表面上具有特定的蛋白质,标记有彩色或荧光分子的抗体可以结合,使我们能够使用FACS对其进行识别和分类,然而,很少有这样的标记物可用于分离视锥细胞和视杆细胞。我们打算将一个报告基因引入一个重要的视网膜基因,标志着他们的分化锥和杆。荧光报告基因的存在将允许我们使用上述细胞选择策略来纯化这些细胞。然后,我们可以使用各种体外干细胞测定和电生理学分析来询问这些细胞是否表现出与视杆细胞和视锥细胞相关的特性。如果成功,这种方法将使我们能够前瞻性地分离视杆细胞和视锥细胞,确定它们的分子表型,并在视网膜疾病的动物模型中测试它们恢复视力的能力。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Coculture techniques for modeling retinal development and disease, and enabling regenerative medicine.
Using Zinc Finger Nuclease Technology to Generate CRX-Reporter Human Embryonic Stem Cells as a Tool to Identify and Study the Emergence of Photoreceptors Precursors During Pluripotent Stem Cell Differentiation.
  • DOI:
    10.1002/stem.2240
  • 发表时间:
    2016-02
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Collin J;Mellough CB;Dorgau B;Przyborski S;Moreno-Gimeno I;Lako M
  • 通讯作者:
    Lako M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Majlinda Lako其他文献

Animal Models for Limbal Stem Cell Deficiency: A Critical Narrative Literature Review
  • DOI:
    10.1007/s40123-023-00880-0
  • 发表时间:
    2024-01-27
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Eray Atalay;Burcugül Altuğ;Mert Egemen Çalışkan;Semih Ceylan;Zeynep Serra Özler;Gustavo Figueiredo;Majlinda Lako;Francisco Figueiredo
  • 通讯作者:
    Francisco Figueiredo
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity
多能干细胞衍生的视网膜疾病模型:阐明发病机制、评估新疗法和评估毒性
  • DOI:
    10.1016/j.preteyeres.2024.101248
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    14.700
  • 作者:
    Marzena Kurzawa-Akanbi;Nikolaos Tzoumas;Julio C. Corral-Serrano;Rosellina Guarascio;David H. Steel;Michael E. Cheetham;Lyle Armstrong;Majlinda Lako
  • 通讯作者:
    Majlinda Lako
Unravelling genotype-phenotype correlations in Stargardt disease using patient-derived retinal organoids
利用患者来源的视网膜类器官解开斯特格病中的基因型-表型相关性
  • DOI:
    10.1038/s41419-025-07420-7
  • 发表时间:
    2025-02-19
  • 期刊:
  • 影响因子:
    9.600
  • 作者:
    Avril Watson;Rachel Queen;Luis Ferrández-Peral;Birthe Dorgau;Joseph Collin;Andrew Nelson;Rafiqul Hussain;Jonathan Coxhead;Michael McCorkindale;Robert Atkinson;Darin Zerti;Valeria Chichagova;Ana Conesa;Lyle Armstrong;Frans P. M. Cremers;Majlinda Lako
  • 通讯作者:
    Majlinda Lako

Majlinda Lako的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Majlinda Lako', 18)}}的其他基金

Off-the-shelf hypoimmunogenic photoreceptors for treatment of blinding retinal disease
现成的低免疫原性光感受器用于治疗致盲性视网膜疾病
  • 批准号:
    EP/Y031016/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant
To assess the engraftment of hESC-derived photoreceptors and their ability to restore vision in early and advanced stages of Retinitis Pigmentosa.
评估 hESC 来源的光感受器的植入及其在色素性视网膜炎早期和晚期恢复视力的能力。
  • 批准号:
    MR/X001687/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant
Elucidating splicing factor function and retinal splicing programmes: developing new therapeutic strategies for splicing factor retinitis pigmentosa
阐明剪接因子功能和视网膜剪接方案:开发剪接因子色素性视网膜炎的新治疗策略
  • 批准号:
    MR/T017503/1
  • 财政年份:
    2020
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant
Assessing SARS-CoV-2 entry, replication and prevention in a primary human conjunctival cell model and organ cultured cornea/conjunctiva.
评估原代人类结膜细胞模型和器官培养角膜/结膜中 SARS-CoV-2 的进入、复制和预防。
  • 批准号:
    BB/V01126X/1
  • 财政年份:
    2020
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant
A single cell sequencing approach to determine the heterogeneity, dynamics and cell fate decisions of retinal progenitor cells in vivo and in vitro
一种单细胞测序方法,用于确定体内和体外视网膜祖细胞的异质性、动态和细胞命运决定
  • 批准号:
    BB/T004460/1
  • 财政年份:
    2020
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant
Understanding the molecular and cellular complexity of human cornea through single cell analyses
通过单细胞分析了解人类角膜的分子和细胞复杂性
  • 批准号:
    MR/S035826/1
  • 财政年份:
    2018
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant
A state of the art multiparametric flow cytometry analysis system for multidisciplinary stem cell research
用于多学科干细胞研究的最先进的多参数流式细胞术分析系统
  • 批准号:
    BB/E012841/1
  • 财政年份:
    2007
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Research Grant

相似国自然基金

基于 IFI44-PRDX1 轴的 ZINC000003938686 对 肾透明细胞癌侵袭转移的抑制作用及机制研 究
  • 批准号:
    Y24H310021
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
分泌性蛋白Zinc-a2-glycoprotein在遗传性扩张型心肌病发生发展中的作用与机制研究
  • 批准号:
    82070391
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
基于Zinc-ZIPs/ZNTs-MTFs轴介导锌稳态失衡致大骨节病软骨细胞外基质代谢障碍作用机制
  • 批准号:
    81803179
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
基于Zinc-ZIP8-MTF1轴研究“祛止补益”法治疗膝骨关节炎的作用机制
  • 批准号:
    81574007
  • 批准年份:
    2015
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
系列酞菁光敏剂抗肿瘤活性研究
  • 批准号:
    30973567
  • 批准年份:
    2009
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目

相似海外基金

Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases
使用工程锌指核糖核酸酶抑制致癌 RNA 调节子
  • 批准号:
    10369661
  • 财政年份:
    2021
  • 资助金额:
    $ 15.24万
  • 项目类别:
Therapeutic platform to treat disease lung using enucleated mesenchymal stem cells0/01/2021
使用去核间充质干细胞治疗肺部疾病的治疗平台0/01/2021
  • 批准号:
    10257613
  • 财政年份:
    2021
  • 资助金额:
    $ 15.24万
  • 项目类别:
Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases
使用工程锌指核糖核酸酶抑制致癌 RNA 调节子
  • 批准号:
    10571941
  • 财政年份:
    2021
  • 资助金额:
    $ 15.24万
  • 项目类别:
Targeted therapeutic delivery to diseased lungs using enucleated mesenchymal stem cells
使用去核间充质干细胞向患病肺部进行靶向治疗
  • 批准号:
    10156129
  • 财政年份:
    2021
  • 资助金额:
    $ 15.24万
  • 项目类别:
Development of a detection system for epigenetic modifications using enzyme fused zinc finger protein
使用酶融合锌指蛋白开发表观遗传修饰检测系统
  • 批准号:
    15J08615
  • 财政年份:
    2015
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Dissecting the Genetics of Human Hemostatic Disorders Using Zebrafish
使用斑马鱼剖析人类止血疾病的遗传学
  • 批准号:
    9243287
  • 财政年份:
    2015
  • 资助金额:
    $ 15.24万
  • 项目类别:
Dissecting the Genetics of Human Hemostatic Disorders Using Zebrafish
使用斑马鱼剖析人类止血疾病的遗传学
  • 批准号:
    9032531
  • 财政年份:
    2015
  • 资助金额:
    $ 15.24万
  • 项目类别:
Genetic Modulation of iPS Cells in HLA Loci Using Zinc Finger Nucleases
使用锌指核酸酶对 HLA 基因座中的 iPS 细胞进行遗传调节
  • 批准号:
    26670799
  • 财政年份:
    2014
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of TDP-43 C-terminal deficient mice using zinc finger nuclease and application to the model for amyotrophic lateral sclerosis
锌指核酸酶TDP-43 C末端缺陷小鼠的建立及其在肌萎缩侧索硬化症模型中的应用
  • 批准号:
    25461271
  • 财政年份:
    2013
  • 资助金额:
    $ 15.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Attenuated malaria sporozoite vaccine using a P. falciparum blood-stage auxotroph
使用恶性疟原虫血期营养缺陷型的减毒疟疾子孢子疫苗
  • 批准号:
    8607502
  • 财政年份:
    2013
  • 资助金额:
    $ 15.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了